Purpose Pregnant women are particularly susceptible to sleep-disordered breathing. Obstructive sleep apnea (OSA) in pregnancy is associated with poor pregnancy and fetal outcomes. Oxidative stress caused by intermittent hypoxemia and reoxygenation may impact pregnancy health. We hypothesize that pregnant women with OSA have a pronounced oxidative stress profile. Methods A case-control study was performed to study oxidative stress markers in the serum of pregnant women with or without OSA. Patients with OSA were identified between 2003 and 2009. Contemporaneous controls were pregnant subjects without apnea, gasping, or snoring around the time of delivery. Serum markers of oxidative and carbonyl stress were measured by spectrophotometric/fluorometric methods. Multiple linear regression analysis was used with a model including age, body mass index at delivery, history of diabetes, and gestational age.
Introduction
Sleep-related breathing disorders are a spectrum of disorders that consist of airflow limitation, hypoxemia, and/or arousals. Obstructive sleep apnea (OSA) is a common sleep-related breathing disorder, with obesity being its strongest risk factor. OSA has been shown to be associated with a variety of adverse outcomes such as diabetes mellitus type 2 [1] , cardiovascular complications including hypertension [2] , stroke [3] , and a higher all-cause mortality [4, 5] .
Pregnant women are particularly susceptible to sleepdisordered breathing, with multiple large studies showing snoring occurs in up to a third of pregnant women in late gestation [6, 7] . In a small cohort study of 150 pregnant women with obesity, the prevalence of OSA was 15% [8] . OSA in pregnancy is associated with an increased risk of preeclampsia, gestational diabetes [6, 9] , and reduced birth weight [10] . One of the proposed pathophysiologic mechanisms for OSAassociated consequences is oxidative stress due to intermittent hypoxemia and reoxygenation [11] .
Oxidative stress arises from the imbalance between the high production of reactive oxygen species and low antioxidant defense. It leads to damage of lipids, proteins, and DNA. Oxidative stress is closely related to carbonyl stress since many products of lipid peroxidation are carbonyls that further react with amines and induce structural as well as functional changes to proteins. Some evidence suggests that carbonyl products, rather than the initial oxidative insult, are the culprit in causing cellular damage [12] . Oxidative stress has been recognized as the crucial mechanism of several disorders, including cardiovascular disease, diabetes, and pregnancy complications [13] , as well as OSA [14, 15] . The link between OSA and oxidative stress is thought to be related to intermittent hypoxemia [11] . The severity of OSA, in particular the oxygen desaturation index, has been found to be independently associated with oxidative stress [16] . Other evidence that oxygen desaturation and tissue hypoxia are the hallmark of injury in OSA during pregnancy is suggested by the investigators of a recent study that identified a high expression of a tissue marker of cellular hypoxia, carbonic anhydrase IX, in placental tissue of women with OSA during pregnancy compared to controls [17] . Animal experiments have shown that antioxidants could be beneficial in OSA confirming the role of oxidative stress in this sleeprelated disorder [18] . On the other hand, intermittent hypoxia has also been suggested to have some protective effects against some cardiovascular complications [19] and may even have some therapeutic benefit in patients with COPD as it may improve ventilation [20] . Given the complicated hormonal and physiological milieu of pregnancy, which includes a higher inflammatory state, it is unclear how OSA would impact oxidative stress.
Several methods can be used for the quantification of oxidative and carbonyl stress. Markers for oxidative stress include advanced oxidation protein products (AOPP) as a measure of protein damage. Carbonyl stress can be measured by advanced glycation end products (AGEs) or fructosamine concentrations. To counter oxidative/carbonyl stress, the body absorbs exogenous or produces endogenous antioxidants, which can be measured as total antioxidant capacity (TAC).
We hypothesized that pregnant women with sleep apnea have alterations in oxidative and carbonyl stress markers compared to pregnant controls. This study aims to evaluate the changes of oxidative and carbonyl stress markers as well as antioxidants in pregnant women with OSA.
Materials and methods

Study population
A case-control study was performed using serum of pregnant women with or without OSA. The Institutional Review Boards for Human Studies at Rhode Island Hospital and Women and Infants Hospital of Rhode Island in Providence, RI, approved the study. Pregnant women with OSA were identified from 2003 to 2009 if they had OSA documented by the International Classification of Diseases-9 codes and had a vaginal or cesarean delivery. Medical records were reviewed to confirm documentation of OSA history, an available polysomnography study at the institution, or a documented prescription for continuous positive airway pressure (CPAP) for OSA if polysomnography was performed at an outside institution and was not available for review. The timing of the diagnosis of OSA in relation to pregnancy and gestational age could not be consistently ascertained. As previously described [21, 22] , only subjects with OSA who had undergone prenatal screening during pregnancy and had stored residual serum samples were included in this study.
Contemporaneous control subjects were identified from a database of English-speaking pregnant women recruited from the same population as the controls from 2006 to 2008. These women were screened for sleep-disordered breathing around the time of delivery using the multivariable apnea prediction index [23] regarding snoring, gasping, and witnessed apneas in a cross-sectional study [6] . Answers were scored from 0 (never) to 4 (always). Participants who scored zero in all three questions and had available residual second trimester serum samples were identified as controls and included in the study. This study excluded subjects who had fetal demise during the index pregnancy.
Biochemical analyses
Markers of oxidative stress (AOPP), carbonyl stress (AGEs, fructosamine), and TAC were measured in the serum of OSA patients and controls. Serum was stored at −80°C before analyses. For the detection and quantification of the particular biochemical markers, established spectrophotometric/ fluorometric methods were used, as previously described in detail elsewhere [18] . For AOPP measurements, samples were incubated with glacial acetic acid and concentrations were calculated from absorbance values at 340 nm. Samples were diluted in phosphate-buffered saline for AGE measurements. Samples were incubated with 2,2′ -azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) and hydrogen peroxide in acetate buffer for TAC measurements. AGEs were measured with excitation at 370 nm and emission at 440 nm. TAC measurements were conducted at 660 nm.
AOPP and AGEs were normalized to total proteins measured using bicinchoninic acid. For all methods, the intraassay coefficients of variation were below 10%. The sensitivity of the assays varies, but these methods have been successfully used for salivary analysis with concentrations lower by an order of magnitude [24] . Three fresh pregnancy samples were frozen and thawed up to four times to verify sample stability and assay reproducibility in the study samples.
During the analysis of oxidative and carbonyl stress markers, investigators were blinded to the OSA or control status.
Statistical analyses
Statistical analysis was conducted using the SAS© software, version 9.3 (SAS Institute Inc., Cary, NC, USA). Descriptive analyses were performed with mean, median, minimum, maximum, and standard deviation based on data distribution. Fisher's exact test and Student's t tests were used for bivariate analysis. Multivariable linear regression analysis was used to compare the markers between controls and cases. Models included in the regression analyses included age, body mass index, gestational age, and a diagnosis of diabetes mellitus.
Results
Clinical characteristics
Fifty-five cases were identified, of which 23 had residual serum available for biomarker testing. Among the 23 cases, four had documented CPAP prescription. A total of 1000 control subjects were initially recruited, of which 321 had scored zero for snoring, gasping, and witnessed apneas. Of the 321, 41 controls had residual serum for testing. The mean age of the cases and controls was 29.2 ± 5.9 and 26.5 ± 6.4 years, respectively (Table 1) . Body mass index (BMI) was significantly higher in the cases than in the controls.
The prevalence of comorbidities such as diabetes (all types) was significantly higher in the group with OSA, but prevalence of preeclampsia was similar in both groups. Gestational age at birth was smaller in women with OSA, but the difference did not reach statistical significance (Table 1) .
Women without available serum samples were compared to women with available serum samples who were included in the study for demographics, comorbidities, and pregnancy outcomes. There were no significant differences observed between the two groups in age, weight and body mass index at sampling, history of pre-gestational diabetes and chronic hypertension, development of gestational diabetes or hypertension during the index pregnancy, as well as gestational age at delivery and mean birth weight (data not shown).
Median apnea hypopnea index (AHI) was 15.4 events per hour with an interquartile range of 22.6 events per hour for those with polysomnography data. The majority of women had mild disease (46%), defined as having an AHI 5-14.9 events per hour, 23% had moderate disease (AHI 15-29.9 events per hour), and 31% had severe disease (AHI ≥30 events per hour). Median nadir oxygen saturation was 84% and interquartile range was 7%. Median percent time spent at oxygen saturation below 90% was 3.65% and interquartile range was 11.1%.
Biochemical markers
Measurements were reproducible and stable over four freeze thaw cycles in three samples for all assays (mean recovery 96% AGES, 87% fructosamine, 116% AOPP, and 100% TAC).
Markers of oxidative stress were compared between the group with OSA and controls. AOPP concentrations were significantly lower in women with OSA compared to controls (5.2 versus 6.0 μmol/g, respectively, p = 0.04; Fig. 1 ). Carbonyl stress also appeared to be significantly lower in pregnant women with OSA compared to controls. AGE levels were 19,432 AU/g in cases compared to 27,344 AU/g in controls (p < 0.0001), and fructosamine levels were 7.9 mmol/l in pregnant women with OSA compared to 9.6 mmol/l in controls (p < 0.05). Antioxidant status measured as TAC was significantly higher (618.2 vs. 586.4 μmol/L, p < 0.0001) in patients with OSA when compared to controls.
Using multivariable logistic regression analysis, with a model that included age, BMI, diabetes, and gestational age at sampling, the association between OSA status and oxidative stress measured by AOPP was no longer significant. In contrast, the association of OSA with reduced carbonyl stress as measured by AGEs remained significant after adjusting for the above covariates (p < 0.01) ( Table 2 ). Antioxidant capacity was no longer significant after adjusting for covariates. Figure 2 shows the relationship between the model adjusted for age and diabetes and obesity. Antioxidant capacity decreased with increasing BMI, while carbonyl stress measured by AGEs increased with rising BMI.
Discussion
As sleep-disordered breathing and OSA have been linked to adverse pregnancy outcomes such as preeclampsia and gestational diabetes, oxidative stress related to repetitive episodes of hypoxia and reoxygenation has been proposed as one of the hypothetical mechanisms underlying this association [25, 26] . Based on this study, pregnant women with OSA have higher levels of antioxidant capacity and lower levels of oxidative and carbonyl stress markers in the second trimester when compared to pregnant women at low risk for OSA and sleep-disordered breathing at a similar stage in pregnancy.
Oxidative stress markers were no longer significantly lower in women with OSA once adjusted for covariates. The direction of these markers in OSA is opposite of the observed effect of BMI (Fig. 2 ) and the expected effect of pregnancy complications. To our knowledge, this is the first study that has evaluated oxidative or carbonyl stress in pregnant women with OSA. Both pregnancy and OSA may impact oxidative and carbonyl stress [27] [28] [29] [30] [31] . AOPP concentrations increase in the first and second trimesters of healthy pregnancies compared to nonpregnant women [32] . AOPP reaches higher concentrations in mild and severe preeclampsia [33] , as well as in gestational diabetes [34] compared to healthy pregnant controls. Similarly, studies measuring advanced glycation end products showed that women with pre-gestational diabetes had higher levels of AGEs compared to normoglycemic controls and women with gestational diabetes [35] [36] [37] . The advanced glycation end product system was also implicated in the pathogenesis of preeclampsia in some studies [38] . TAC levels increase significantly throughout pregnancy [39] , are highest in labor at 37 to 41 weeks [40] , the period of greatest stress in pregnancy, and lower in pregnancies complicated by pregestational diabetes and preeclampsia [41, 13] . Though a higher prevalence of these comorbidities would have been expected to increase the oxidative and carbonyl stress markers and lower antioxidant capacity in the OSA group, AOPP and AGE levels were observed to be lower and TAC higher in the OSA group, despite these comorbidities. These findings may suggest that although OSA and pregnancy complications coexist and oxidative stress likely plays a role in these complications in general, OSA does not appear to contribute to these complications via oxidative stress. In addition, as our entire sample-both cases and controls-consisted of pregnant women, it is unlikely that the findings in our study are influenced by the pregnant state or pregnancy stage since we adjusted levels for gestational age at sampling. AGEs advanced glycation end products, AOPP advanced oxidation protein products, g grams, L liters, TBARS thiobarbituric acid reactive substances, OSA obstructive sleep apnea, SD standard deviation, TAC antioxidant capacity, mmol millimoles, μmol micromole P value < 0.05; **P value < 0.01; ***P value < 0.001 a b Fig. 2 Effect of body mass index on the age and diabetes-adjusted model of carbonyl stress markers, *p < 0.01 (a) and total anti-oxidant capacity (b). AGEs advanced glycation end product, TAC total antioxidant capacity OSA is a condition known to be associated with an enhanced oxidative stress and reduced antioxidant capacity in the nonpregnant population [42] . Hypoxia/reoxygenation injury that is characteristic of OSA leads to an increased production of reactive oxygen species [16, 43] , as demonstrated by Dyugovskaya et al. [44] , and increased carbonyl stress, as demonstrated by higher AGEs levels that correlate with the severity of OSA [45, 46] . On the other hand, possible benefits of intermittent hypoxia through increased sensitivity to hypoxia, increased hematopoiesis, alveolar ventilation, diffusion capacity, and alterations in the autonomic nervous system [47] have been described. Protection against ischemia reperfusion injury has also been described [48] . Intermittent hypoxia is believed to trigger antioxidant defense mechanisms and help stabilize cellular membranes. This may in fact suggest that OSA in pregnancy may have a protective effect with a favorable oxidative stress profile where intermittent hypoxia may result in short episodes of stress similar to labor, causing the body to respond with increased antioxidant capacity. However, it is also possible that an upregulation of the counterregulatory mechanisms of the antioxidant pathways, as a response to augmented oxidative stress, occurs in response to obstructive events and therefore counteracts the oxidative stress pathways.
Another possible explanation is that the oxidative and carbonyl system may need a long duration of an insult to be appropriately activated. As some women in our sample were diagnosed with OSA during pregnancy and the uncertainty regarding whether the condition predated pregnancy, it is possible that they may not have had the insult for long enough duration of time. Though this hypothesis may explain why levels were not elevated in women with OSA and comorbidities, it would not explain why levels were in fact lower than those without OSA, and lower concentrations of these stress markers may, in fact, support the alternative possibility of a protective effect of intermittent hypoxia. However, it is also possible that unknown confounders may have altered the levels of antioxidants in controls in our sample.
Findings from this study need to be interpreted in the context of several limitations, however, including small sample size of cases and controls with available residual serum. As control subjects were obtained from a convenience sample that was screened for sleep-disordered breathing and had residual serum available for testing, we did not have polysomnography data in this group to definitely exclude the diagnosis of OSA which could have resulted in the null findings. Furthermore, given the retrospective nature of the study, we were unable to ascertain adherence and compliance with therapy in patients whose records indicated that therapy has in fact been prescribed (n = 4). It is also possible that other subjects had been on CPAP, but therapy was not documented in the obstetric record. Prior studies by the investigators have shown that continuous positive airway pressure therapy for 1 month reduces levels of the same oxidative and carbonyl stress markers without impacting total antioxidant capacity [18] . However, in a recent randomized controlled trial designed as an intent-to-treat trial by Paz y Mar et al. [49] , there was no significant reduction in oxidative stress at 2 months measured by urinary F2 isoprostane and leukocyte oxidant generating enzyme myeloperoxidase among participants treated with CPAP as compared to those treated with sham CPAP. However, morning arterial stiffness measures using pulse wave velocity were significantly reduced by the use of CPAP in this study. The authors of the study concluded that improvements in cardiovascular outcomes in response to CPAP therapy may not be mediated by oxidative pathways. It is possible that women who are more symptomatic and reporting daytime sleepiness may have a more pronounced inflammatory and oxidative profile compared to women who are not. However, data on daytime sleepiness were not available in the cases for analysis in this study. Furthermore, previous studies of salivary oxidative stress markers have shown some circadian variation in salivary levels of stress markers [24] with levels of oxidative and carbonyl stress markers being higher in the morning than in the evening. It is possible that potential circadian variation [50] in these levels may have impacted our results.
Conclusion
In summary, unlike the general population, pregnant women with OSA have lower levels of carbonyl stress markers compared to pregnant controls. Though these findings suggest a possible protective effect of intermittent hypoxia, results from our study would need to be confirmed in a prospective sample of incident OSA with standardization of sampling time and prior to initiation of therapy.
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